US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
Patent 11648317 was granted and assigned to Genentech on May, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.